ANGPTL3 and metabolic dysfunction-associated steatohepatitis: In a cross-sectional investigation of obese subjects, both hepatic and plasma ANGPTL3 were higher in individuals with NALFD and positively correlated with hepatic steatosis and histological markers of NASH (267).